Cargando…
Lifetime Cannabis Use Is Not Associated With Negative Beliefs About Medication in Patients With First Treatment Psychosis
OBJECTIVE: Cannabis use is common among patients with psychosis, and along with negative beliefs about medication, it has been found to predict poor adherence to antipsychotic drug treatment. Such lack of adherence to antipsychotic drug treatment increases the risk of poor clinical outcomes and rela...
Autores principales: | Gjerde, Priyanthi B., Steen, Synne W., Vedal, Trude S. J., Steen, Nils Eiel, Reponen, Elina J., Andreassen, Ole A., Steen, Vidar M., Melle, Ingrid |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9001842/ https://www.ncbi.nlm.nih.gov/pubmed/35422717 http://dx.doi.org/10.3389/fpsyt.2022.824051 |
Ejemplares similares
-
Sex-Specific Effect of Serum Lipids and Body Mass Index on Psychotic Symptoms, a Cross-Sectional Study of First-Episode Psychosis Patients
por: Gjerde, Priyanthi B., et al.
Publicado: (2021) -
Predictors for Antipsychotic Dosage Change in the First Year of Treatment in Schizophrenia Spectrum and Bipolar Disorders
por: Ringen, Petter Andreas, et al.
Publicado: (2019) -
Adiponectin Is Related to Cardiovascular Risk in Severe Mental Illness Independent of Antipsychotic Treatment
por: Reponen, Elina J., et al.
Publicado: (2021) -
Improvement in verbal learning over the first year of antipsychotic treatment is associated with serum HDL levels in a cohort of first episode psychosis patients
por: Gjerde, Priyanthi B., et al.
Publicado: (2019) -
Atherogenic Lipid Ratios Related to Myeloperoxidase and C-Reactive Protein Levels in Psychotic Disorders
por: Reponen, Elina J., et al.
Publicado: (2020)